Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications
DOI 10.1038/ncomms12150

Cited by (1,003)

Items 1,001–1,003 of 1,003

  1. Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights
    Shi, Lei, Zhang, Ziying, Mei, Song, Wang, Zerui, Xu, Zhe, Yao, Weiqi, Liu, Limin, Yuan, Mengqi, Pan, Yuefei, Zhu, Kaidi et al. · 2025 · Signal Transduction and Targeted Therapy
  2. Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer
    Caronni, Nicoletta, Montaldo, Elisa, Mezzanzanica, Luca, Cilenti, Francesco, Genua, Marco, Ostuni, Renato · 2021 · Immunological Reviews
  3. Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma
    Lu, Jun, Duan, Yumei, Liu, Pinbo, He, Xiang, Yang, Yiping, Zhang, Ran, Weng, Liang · 2023 · The Journal of Pathology